title: Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy.
authors.affiliation: Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK. charles.lawrie@ndcls.ox.ac.uk
authors.forename: Charles H
authors.initials: CH
authors.lastname: Lawrie
authors.forename: Christopher D O
authors.initials: CD
authors.lastname: Cooper
authors.forename: Erica
authors.initials: E
authors.lastname: Ballabio
authors.forename: Jianxiang
authors.initials: J
authors.lastname: Chi
authors.forename: Daniela
authors.initials: D
authors.lastname: Tramonti
authors.forename: Christian S R
authors.initials: CS
authors.lastname: Hatton
mesh_terms: D001402:B-Lymphocytes / Q000378:metabolism; D016022:Case-Control Studies; D002460:Cell Line; D015972:Gene Expression Regulation, Neoplastic; D019337:Hematologic Neoplasms / Q000378:metabolism*; D006801:Humans; D035683:MicroRNAs / Q000096:biosynthesis*; D043244:Ribonuclease III / Q000235:genetics; D013601:T-Lymphocytes / Q000378:metabolism
chemical_list: D035683:MicroRNAs; C517918:DROSHA protein, human; D043244:Ribonuclease III